A fourteen-year review of breast pathology at a rural referral center in western Kenya

Background: Breast cancer has a low incidence in Africa compared with other continents. Of breast cancer reported in Africa, middle and eastern Africa is reported with the lowest incidence. In general, there is a paucity of information about breast cancer in Africa. Breast cancer evaluation and treatment is plagued with inadequate resource and screening facility throughout sub-Saharan Africa. Therefore, it is difficult to adequately assess incidence or prevalence without appropriate cancer or death registries. To our knowledge, no data exists for breast cancer treated in rural Kenya.Methods: Review of all surgical pathology reports was performed from January 31, 1993 to August 31, 2007 at Tenwek Hospital, a 300 bed referral center located in Bomet, Kenya. Records were searched for any breast specimen or specimen related to breast disease such as metastatic breast disease.Results: For the studied period, a total of 118 breast cancers were identified from pathology report records. Men accounted for 13 (11.02%) of all breast cancers. The average age for men was 69 years (std 10.6). The average age of women (n=105) was 51.2 years (std 15.6). The difference between the mean ages among men and women was statistically significant (p=0.000195). Grades were listed for only 55 of 118 specimens. Grade 3 was recorded in 61.8% (34/55). Women, aged 50 years or less, comprised 59.3% of all women recorded ages. In females, Grade 1 occurred in 7.1%, Grade 2 in 39.3%, and Grade 3 in 53.6%. Average age for Grade 1 histology is 37.5 years (std 2.1), Grade 2 average was 38.3 years (std 5.9) and Grade 3 average age was 40.8 years (std 5.7). The majority of males had IDC (12/13) with one case of NHL and melanoma of the breast

A loop-mediated isothermal amplification (LAMP) assay for the detection of Cryptotermes brevis West Indian drywood termite (Blattodea: Kalotermitidae)

Cryptotermes brevis is one of the most destructive invasive termites in the subtropics and tropics and is a common biosecurity intercept at the Australian border. Drywood termite species are cryptic and difficult to identify morphologically in situations when soldiers or imagos are unavailable. We developed a novel DNA based loop-mediated isothermal amplification (LAMP) assay to detect C. brevis and differentiate it from other drywood termites. Validated voucher specimens of 30 different drywood termite species were obtained from several insect collections from which DNA was extracted and amplified. The amplicons containing partial mitochondrial 16S rRNA were sequenced and a DNA database was created from which C. brevis LAMP primers were developed, optimized, and tested. The assay was assessed against a range of target and non-target species and found to be specific, successfully amplifying the target specimens of C. brevis in under 30 min. Amplification success was variable against C. brevis faecal pellets due to minute, unmeasurable or degraded DNA. This LAMP test is a new tool for the rapid detection of C. brevis that will enable faster and less destructive management of drywood termite infestations

Successful induction of ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kallmann's syndrome

The induction of ovulation in women with hypogonado-trophic hypogonadism requires follicle stimulating hormone (FSH) for follicular growth and both FSH and luteinizing hormone (LH) to induce optimal follicular steroidogenesis. The development of human recombinant FSH and LH means that individually tailored doses of both hormones can be used with the aim of inducing unifollicular ovulation. This report describes the use of recombinant human FSH and LH for the induction of ovulation and conception in the second cycle of treatment, and subsequently a successfully completed pregnancy in a woman with Kallmann's syndrom

Incorporation of Density Matrix Wavefunctions in Monte Carlo Simulations: Application to the Frustrated Heisenberg Model

We combine the Density Matrix Technique (DMRG) with Green Function Monte Carlo (GFMC) simulations. The DMRG is most successful in 1-dimensional systems and can only be extended to 2-dimensional systems for strips of limited width. GFMC is not restricted to low dimensions but is limited by the efficiency of the sampling. This limitation is crucial when the system exhibits a so-called sign problem, which on the other hand is not a particular obstacle for the DMRG. We show how to combine the virtues of both methods by using a DMRG wavefunction as guiding wave function for the GFMC. This requires a special representation of the DMRG wavefunction to make the simulations possible within reasonable computational time. As a test case we apply the method to the 2-dimensional frustrated Heisenberg antiferromagnet. By supplementing the branching in GFMC with Stochastic Reconfiguration (SR) we get a stable simulation with a small variance also in the region where the fluctuations due to minus sign problem are maximal. The sensitivity of the results to the choice of the guiding wavefunction is extensively investigated. We analyse the model as a function of the ratio of the next-nearest to nearest neighbor coupling strength. We observe in the frustrated regime a pattern of the spin correlations which is in-between dimerlike and plaquette type ordering, states that have recently been suggested. It is a state with strong dimerization in one direction and weaker dimerization in the perpendicular direction.Comment: slightly revised version with added reference

Observation of Parity Violation in the Omega-minus -> Lambda + K-minus Decay

The alpha decay parameter in the process Omega-minus -> Lambda + K-minus has been measured from a sample of 4.50 million unpolarized Omega-minus decays recorded by the HyperCP (E871) experiment at Fermilab and found to be [1.78 +/- 0.19(stat) +/- 0.16(syst)]{\times}10^{-2}. This is the first unambiguous evidence for a nonzero alpha decay parameter, and hence parity violation, in the Omega-minus -> Lambda + K-minus decay.Comment: 10 pages, 7 figure

An accurate and precise high-performance liquid chromatography method for the rapid quantification of the novel HIV integrase inhibitor raltegravir in human blood plasma after solid phase extraction

The quantification of the HIV integrase inhibitor raltegravir in blood plasma is described using solid phase extraction (SPE) coupled with an accurate high-performance liquid chromatography assay with ultraviolet (UV) detection. The method was validated over the range of 20–10,000ng/mL using simple sample preparation and chromatography. The SPE method was optimized to be selective and highly efficient. The buffer’s ionic strength and pH were optimized for retaining RAL and the internal standard on the column, the percentage of methanol was optimized in the cleaning step to remove unwanted plasma contaminants, and the type and amount of acid was optimized for complete elution of the compounds. This method has no interference with other potentially co-administered antiretrovirals or common drugs. Average recoveries for the extraction method were consistently high: 90% for raltegravir and 90% for the internal standard diazepam. This method was found to be accurate and precise. Within day (n=6) and between day (n=18) accuracies ranged from 97.5% to 104.4%. Within-day (n=6) and between-day (n=18) precision ranged from 1.4% to 3.8%, and from 2.4% to 7.9%, respectively. This is the first published method to use simple UV technology and reliable SPE extraction methodology for the quantification of raltegravir in human plasma. This method can be easily implemented in most bioanalytical laboratories